journal article·2023-05-30Open access

Functional L-Arginine Derivative as an Efficient Vector for Intracellular Protein Delivery for Potential Cancer Therapy

Xiao He, Yannv Qu, Su Xiong, Zhiru Jiang, Yaqin Tang, Fei Yan, Yuanfei Deng, Yansun Sun

Abstract

The utilization of cytosolic protein delivery is a promising approach for treating various diseases by replacing dysfunctional proteins. Despite the development of various nanoparticle-based intracellular protein delivery methods, the complicated chemical synthesis of the vector, loading efficiency and endosomal escape efficiency of proteins remain a great challenge. Recently, 9-fluorenylmethyloxycarbonyl (Fmoc)-modified amino acid derivatives have been used to self-assemble into supramolecular nanomaterials for drug delivery. However, the instability of the Fmoc group in aqueous medium restricts its application. To address this issue, the Fmoc ligand neighboring arginine was substituted for dibenzocyclooctyne (DBCO) with a similar structure to Fmoc to obtain stable DBCO-functionalized L-arginine derivative (DR). Azide-modified triethylamine (crosslinker C) was combined with DR to construct self-assembled DRC via a click chemical reaction for delivering various proteins, such as BSA and saporin (SA), into the cytosol of cells. The hyaluronic-acid-coated DRC/SA was able to not only shield the cationic toxicity, but also enhance the intracellular delivery efficiency of proteins by targeting CD44 overexpression on the cell membrane. The DRC/SA/HA exhibited higher growth inhibition efficiency and lower IC50 compared to DRC/SA toward various cancer cell lines. In conclusion, DBCO-functionalized L-arginine derivative represents an excellent potential vector for protein-based cancer therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Virus-based gene therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Geriatrics, Peking University Shenzhen Hospital, Shenzhen 518036, China

Center for Cell and Gene Circuit Design, CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China

Chongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of Technology, Chongqing 400054, China

Funding

Shenzhen Science and Technology Program · Science and Technology research program of Chongqing Education Commission of China · Scientific Research Foundation of Chongqing University of Technology

References (44)

Show source-provided references
1. Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases10.1016/j.coph.2018.05.010 ↗
2. Top product forecasts for 202210.1038/d41573-021-00211-7 ↗
3. Rational Design of Nanocarriers for Intracellular Protein Delivery10.1002/adma.201902791 ↗
4. Combinatorially Designed Lipid-like Nanoparticles for Intracellular Delivery of Cytotoxic Protein for Cancer Therapy10.1002/anie.201311245 ↗
5. Covalent Attachment of Cyclic TAT Peptides to GFP Results in Protein Delivery into Live Cells with Immediate Bioavailability10.1002/anie.201410006 ↗
6. DNA-Mediated Cellular Delivery of Functional Enzymes10.1021/jacs.5b09711 ↗
7. Nanotechnology for protein delivery: Overview and perspectives10.1016/j.jconrel.2015.10.012 ↗
8. Nontoxic nanopore electroporation for effective intracellular delivery of biological macromolecules10.1073/pnas.1818553116 ↗
9. Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts10.1021/acs.chemrev.7b00678 ↗
10. Guanidinium-based “molecular glues” for modulation of biomolecular functions10.1039/C7CS00647K ↗
11. Cell-Penetrating Peptides: From Basic Research to Clinics10.1016/j.tips.2017.01.003 ↗
12. Cell-Penetrating Peptide Mediates Intracellular Membrane Passage of Human Papillomavirus L2 Protein to Trigger Retrograde Trafficking10.1016/j.cell.2018.07.031 ↗
13. General Strategy for Direct Cytosolic Protein Delivery via Protein–Nanoparticle Co-engineering10.1021/acsnano.7b02884 ↗
14. Cellular uptake of large biomolecules enabled by cell-surface-reactive cell-penetrating peptide additives10.1038/s41557-021-00661-x ↗
15. In vivo targeted delivery of antibodies into cancer cells with pH-responsive cell-penetrating poly(disulfide)s
16. Thiol-Mediated Uptake10.1021/jacsau.1c00128 ↗
17. Poly(disulfide)s: From Synthesis to Drug Delivery10.1021/acs.biomac.1c01210 ↗
18. Doxorubicin@ PEPylated interferon-polydisulfide: A multi-responsive nanoparticle for enhanced chemo–protein combination therapy10.1016/j.giant.2020.100040 ↗
19. Approaches and materials for endocytosis-independent intracellular delivery of protein10.1016/j.biomaterials.2022.121567 ↗
20. Bioresponsive nanogels for protein delivery10.1002/VIW.20200136 ↗
21. Fusogenic Liposomes as Nanocarriers for the Delivery of Intracellular Proteins10.1021/acs.langmuir.6b04304 ↗
22. Biodegradable Metal–Organic-Frameworks-Mediated Protein Delivery Enables Intracellular Cascade Biocatalysis and Pyroptosis In Vivo10.1021/acsami.2c14957 ↗
23. Fluoropolymers for intracellular and in vivo protein delivery10.1016/j.biomaterials.2018.08.023 ↗
24. Direct Cytosolic Delivery of Proteins through Coengineering of Proteins and Polymeric Delivery Vehicles10.1021/jacs.9b12759 ↗
25. Intracellular Delivery of Native Proteins Facilitated by Cell-Penetrating Poly(disulfide)s10.1002/ange.201711651 ↗
26. Dynamic Polymer Amphiphiles for Efficient Intracellular and In Vivo Protein Delivery10.1002/adma.202104355 ↗
27. Enzyme-Cleavable Polymeric Micelles for the Intracellular Delivery of Proapoptotic Peptides10.1021/acs.molpharmaceut.6b01178 ↗
28. In Situ Growth of Self-Assembled Protein–Polymer Nanovesicles for Enhanced Intracellular Protein Delivery10.1021/acsami.6b14132 ↗
29. Templated Self-Assembly of a Covalent Polymer Network for Intracellular Protein Delivery and Traceless Release10.1021/jacs.7b01214 ↗
30. Proteins evolve on the edge of supramolecular self-assembly10.1038/nature23320 ↗
31. Assembly reflects evolution of protein complexes10.1038/nature06942 ↗
32. Multitriggered Tumor-Responsive Drug Delivery Vehicles Based on Protein and Polypeptide Coassembly for Enhanced Photodynamic Tumor Ablation10.1002/smll.201602339 ↗
33. Peptide Self-Assembled Nanostructures for Drug Delivery Applications10.1155/2017/4562474 ↗
34. A6 peptide-tagged, ultra-small and reduction-sensitive polymersomal vincristine sulfate as a smart and specific treatment for CD44+ acute myeloid leukemia10.1016/j.jconrel.2020.10.005 ↗
35. The physics of protein self-assembly10.1016/j.cocis.2016.02.011 ↗
36. Deterministic chaos in the self-assembly of β sheet nanotubes from an amphipathic oligopeptide10.1016/j.matt.2021.06.037 ↗
37. Protected Amino Acid–Based Hydrogels Incorporating Carbon Nanomaterials for Near-Infrared Irradiation-Triggered Drug Release10.1021/acsami.9b02482 ↗
38. Amino Acid Coordination Driven Self-Assembly for Enhancing both the Biological Stability and Tumor Accumulation of Curcumin10.1002/anie.201810087 ↗
39. Magnetically Driven Nanotransporter-Assisted Intracellular Delivery and Autonomous Release of Proteins10.1021/acsami.0c12249 ↗
40. Carbamoylated Guanidine-Containing Polymers for Non-Covalent Functional Protein Delivery in Serum-Containing Media10.1002/anie.202116722 ↗
41. Saporin-loaded CD44 and EGFR dual-targeted nanogels for potent inhibition of metastatic breast cancer in vivo10.1016/j.ijpharm.2019.01.040 ↗
42. Fluoropolymers-mediated efficient biomacromolecule drug delivery10.1016/j.medidd.2022.100123 ↗
43. Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo10.1038/s41467-021-25448-z ↗
44. Efficient delivery of cytosolic proteins by protein-hexahistidine-metal co-assemblies10.1016/j.actbio.2021.05.001 ↗